Edition:
India

Neurotrope Inc (NTRP.OQ)

NTRP.OQ on NASDAQ Stock Exchange Capital Market

8.33USD
26 Jun 2019
Change (% chg)

-- (--)
Prev Close
$8.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
19,190
52-wk High
$11.90
52-wk Low
$3.34

Latest Key Developments (Source: Significant Developments)

Neurotrope Announces $22.5 Mln Registered Direct Offering
Monday, 17 Dec 2018 

Dec 17 (Reuters) - Neurotrope Inc ::NEUROTROPE ANNOUNCES $22.5 MILLION REGISTERED DIRECT OFFERING.NEUROTROPE INC - ANNOUNCED PRICING OF REGISTERED DIRECT OFFERING OF 5.0 MILLION SHARES OF COMMON STOCK.NEUROTROPE - EACH SHARE OF COMMON STOCK IS BEING SOLD TOGETHER WITH WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK FOR COMBINED PURCHASE PRICE OF $4.495.  Full Article

Neurotrope Provides Business Update And Reports Q2 2018 Financial Results
Monday, 13 Aug 2018 

Aug 13 (Reuters) - Neurotrope Inc ::NEUROTROPE PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.NEUROTROPE INC - AS OF JUNE 30, 2018, COMPANY HAD APPROXIMATELY $11.8 MILLION OF CASH AND CASH EQUIVALENTS.  Full Article

Neurotrope Inc - On May 4 Neurotrope Bioscience Executed A Services Agreement With Worldwide Clinical Trials
Friday, 11 May 2018 

May 10 (Reuters) - Neurotrope Inc ::NEUROTROPE INC - ON MAY 4 NEUROTROPE BIOSCIENCE EXECUTED A SERVICES AGREEMENT WITH WORLDWIDE CLINICAL TRIALS.NEUROTROPE - DEAL RELATES TO SERVICES FOR CONFIRMATORY PHASE 2 STUDY OF BRYOSTATIN IN TREATMENT OF MODERATELY SEVERE TO SEVERE ALZHEIMERS DISEASE.NEUROTROPE INC - NEUROTROPE AND NEUROTROPE BIOSCIENCE EXPECT THAT FIRST STUDY SITE WILL BE INITIATED DURING Q2 OF 2018.NEUROTROPE INC - PER AGREEMENT TOTAL ESTIMATED BUDGET FOR SERVICES, INCLUDING PASS-THROUGH COSTS, IS APPROXIMATELY $6.9 MILLION.  Full Article

Neurotrope Appoints Charles S. Ryan As CEO
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Neurotrope Inc ::NEUROTROPE APPOINTS CHARLES S. RYAN AS CHIEF EXECUTIVE OFFICER.NEUROTROPE INC - ‍ APPOINTMENT OF CHARLES RYAN FOLLOWS RESIGNATION OF SUSANNE WILKE, PHD, AS CHIEF EXECUTIVE OFFICER AND DIRECTOR​.NEUROTROPE INC - RYAN BECOMES A DIRECTOR OF COMPANY EFFECTIVE IMMEDIATELY AND WILL ASSUME HIS RESPONSIBILITIES AS CEO EFFECTIVE FEBRUARY 15, 2018.  Full Article